872
Participants
Start Date
June 30, 2014
Primary Completion Date
March 4, 2017
Study Completion Date
March 4, 2017
Chiesi Clinical Trial Site #0401, Lugo
Chiesi Clinical Trial Site #0502, Durham
Chiesi Clinical Trial Site #0301, Hanover
Chiesi Clinical Trial Site #0102, Verona
Chiesi Clinical Trial Site #0504, Cleveland
Chiesi Clinical Trial Site #0104, Ferrara
Chiesi Clinical Trial Site #0103, Pisa
Chiesi Clinical Trial Site #0501, Houston
Chiesi Clinical Trial Site #0503, Denver
Gao, Beijing
Qingling Zhang, Hangzhou
Prof. Dr. Emilio Pizzichini, Florianópolis
Prof. Dr. Alberto Cukier, São Paulo
Prof. Dr. Rafael Stelmach, São Paulo
Chiesi Clinical Trial Site #0101, Napoli
Scichilone, Palermo
Chetta, Parma
Dr. M. Broeders, 's-Hertogenbosch
W. Boersma, Alkmaar
Dr. J. Vroegop, Groningen
Dr. M. vd Berge, Groningen
Chiesi Clinical Trial Site #0201, Montreal
Yuanlin Song, Shanghai
Chiesi Clinical Trial Site #0303, Großhansdorf
Chiesi Clinical Trial Site #0302, Leipzig
Chiesi Clinical Trial Site #0402, Barcelona
Chiesi Farmaceutici S.p.A.
INDUSTRY